Drug Type Small molecule drug |
Synonyms (2R,3R)-2-(2,4-Difluorophenyl)-3-(4-methylene-1-piperidinyl)-1-(1H-1,2,4-triazol-1-yl)-2-butanol, Clenafin Topical Solution, EFCZ + [7] |
Target |
Mechanism fungal CYP51A1 inhibitors(Fungal CYP51A1 inhibitors) |
Therapeutic Areas |
Active Indication |
Inactive Indication- |
Originator Organization |
Active Organization |
Inactive Organization |
Drug Highest PhaseApproved |
First Approval Date US (06 Jun 2014), |
Regulation- |
Molecular FormulaC18H22F2N4O |
InChIKeyNFEZZTICAUWDHU-RDTXWAMCSA-N |
CAS Registry164650-44-6 |
KEGG | Wiki | ATC | Drug Bank |
---|---|---|---|
D10021 | Efinaconazole |
Indication | Country/Location | Organization | Date |
---|---|---|---|
Mycoses | DE | 02 Oct 2024 | |
Onychomycosis | US | 06 Jun 2014 |
Phase 4 | 62 | rnrkcgfvzx(akzomlrsgu) = lxodjgvfkb aiketkyomc (mnwbsmcljf, pzvcszxzre - mjqsjksnsp) View more | - | 01 Nov 2021 | |||
Phase 3 | 40 | isakyzooee(xllxaxacoc) = vmfybjwebc jvfxyvmahc (fkdootzgtc, ldotprlmtz - crqlrjxlue) View more | - | 23 Oct 2019 | |||
Phase 4 | 13 | mxusbdmbks(pqrxjlhzxg) = jjijlzpyqi agjrvrowhe (dhpqgxzqpt, nnaciugxow - voelgmpaqo) View more | - | 20 Mar 2019 | |||
Phase 3 | - | qritonddos(mguddnxvbt) = xtypbzhmag rknoijrxej (swmcxodvvl ) View more | - | 01 Jul 2014 | |||
Vehicle | qritonddos(mguddnxvbt) = mhupygklnu rknoijrxej (swmcxodvvl ) View more | ||||||
Phase 2 | 135 | Efinaconazole 10% solution (with or without semiocclusion) | jcnlibqeap(sxwpjhehbz) = ehmiofrxzn rajrtlekqo (sedgertynq ) View more | - | 01 Feb 2013 | ||
wvbtwqamgq(vypndcoajf) = bmeqcegakx uejvawzjfw (qgfqctptaq ) |